Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Challenging Pharmacokinetics of Mitotane: An Old Drug in Need of New Packaging
Malik Salman Haider, Taufiq Ahmad, Jürgen Gröll, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2021) Vol. 46, Iss. 5, pp. 575-593
Open Access | Times Cited: 19

Showing 19 citing articles:

Polyoxazoline: A review article from polymerization to smart behaviors and biomedical applications
Saba Nemati Mahand, Sanaz Aliakbarzadeh, Armaghan Moghaddam, et al.
European Polymer Journal (2022) Vol. 178, pp. 111484-111484
Closed Access | Times Cited: 63
The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis
Obada Ababneh, Alina Ghazou, Mohmmad M. Alawajneh, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 900-900
Open Access | Times Cited: 5
Mitotane activates ATF4/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells
Aurora Schiavon, L. Saba, Carlotta Evaristo, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117917-117917
Closed Access
In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer
Bashir Lawal, Yu-Cheng Kuo, Maryam Rachmawati Sumitra, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 4901-4913
Open Access | Times Cited: 22
A review of mitotane in the management of adrenocortical cancer
Jaydira Del Rivero, Tobias Else, Julie Hallanger‐Johnson, et al.
The Oncologist (2024) Vol. 29, Iss. 9, pp. 747-760
Open Access | Times Cited: 3
Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma
Barbara Altieri, Otilia Kimpel, Felix Megerle, et al.
European Journal of Endocrinology (2024) Vol. 190, Iss. 2, pp. 139-150
Open Access | Times Cited: 2
Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics
Jie Zhang, Luming Wu, Tingwei Su, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma
Fabiano Flauto, Maria Cristina De Martino, Chiara Vitiello, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4061-4061
Open Access | Times Cited: 2
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care
Elena Ruggiero, Irene Tizianel, Mario Caccese, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5901-5901
Open Access | Times Cited: 7
Powder Self-Emulsifying Drug Delivery System for Mitotane: In Vitro and In Vivo Evaluation
Mohamed Skiba, Valentin Lefébure, Frédéric Bounoure, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1194-1194
Open Access | Times Cited: 1
Glass transition, crystallization kinetics, and inter-conformer relaxation dynamics of amorphous mitotane and related compounds
Michela Romanini, Alex Pérez Valmaseda, Roberto Macovez
International Journal of Pharmaceutics (2022) Vol. 629, pp. 122390-122390
Open Access | Times Cited: 4
Long-term partial response in a patient with liver metastasis of primary adrenocortical carcinoma with adjuvant mitotane plus transcatheter arterial chemoembolization and microwave ablation: a case report
Jianhua Deng, Lihui Wei, Qihuang Fan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Albumin/Mitotane Interaction Affects Drug Activity in Adrenocortical Carcinoma Cells: Smoke and Mirrors on Mitotane Effect with Possible Implications for Patients’ Management
Aurora Schiavon, L. Saba, Gianluca Catucci, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16701-16701
Open Access | Times Cited: 2
Mitotane treatment in adrenocortical carcinoma: mechanisms of action and predictive markers of response to therapy
Barbara Altieri, Enzo Lalli, Antongiulio Faggiano
Minerva Endocrinology (2021) Vol. 47, Iss. 2
Closed Access | Times Cited: 5
Analytical Method Development for Evaluation of Pharmacokinetics and Tissue Distribution of Thiourea-Based Antivirals through nLC/MS-MS
Jitendra Kumar, Purnima Tyagi, Manisha Yadav, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Development and validation of a liquid chromatography coupled to a diode array detector (LC-DAD) method for measuring mitotane (DDD) in plasma samples
Anna Sylvia Ferrari Marques, Atecla Nunciata Lopes Alves, Berenice B. Mendonça, et al.
Clinics (2024) Vol. 79, pp. 100470-100470
Open Access
The Effects of Cumulative Dose and Polymorphisms in CYP2B6 on the Mitotane Plasma Trough Concentrations in Chinese Patients With Advanced Adrenocortical Carcinoma
Xin Liu, Junmei Shang, Qiang Fu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Mitotane in adrenocortical carcinoma: a profile of its use
Matt Shirley
Drugs & Therapy Perspectives (2022) Vol. 38, Iss. 12, pp. 508-519
Open Access | Times Cited: 1
Hemin-Coated Nanoparticles as Drug Delivery Vehicles for Chemotherapeutic Agents in Cancer Therapy
Kailin Feng, Eunsoo Yoo, Daphne Nie, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 22, pp. 20678-20687
Closed Access
Page 1

Scroll to top